Author Index

Search or browse for an author across our entire electronic archive

Search results for: K
Results 111 - 120 of 1824 shown below

  • Kakuma, T

    S Takemoto, K Ushijima, K Kawano, T Yamaguchi, A Terada, N Fujiyoshi, S Nishio, N Tsuda, M Ijichi, T Kakuma, M Kage, D Hori and T Kamura

    Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma

    advance online publication, 2009-07-28 00:00:00.000;

    doi:10.1038/sj.bjc.6605212

  • Kal, H B

    S Y El Sharouni, H B Kal and J J Battermann

    Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy

    doi:10.1038/sj.bjc.6601418

  • Kalantari, H Rezaei

    H Rezaei Kalantari

    Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer

    advance online publication, 2009-09-15 00:00:00.000;

    doi:10.1038/sj.bjc.6605303

  • Kalantaridou, S N

    V Minas, A Rolaki, S N Kalantaridou, J Sidiropoulos, S Mitrou, G Petsas, U Jeschke, E A Paraskevaidis, G Fountzilas, G P Chrousos, N Pavlidis and A Makrigiannakis

    Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation

    advance online publication, 2007-07-31 00:00:00.000;

    doi:10.1038/sj.bjc.6603918

  • Kalaylioglu, Z

    M García-Closas, L A Brinton, J Lissowska, N Chatterjee, B Peplonska, W F Anderson, N Szeszenia-Da ogonbrowska, A Bardin-Mikolajczak, W Zatonski, A Blair, Z Kalaylioglu, G Rymkiewicz, D Mazepa-Sikora, R Kordek, S Lukaszek and M E Sherman

    Established breast cancer risk factors by clinically important tumour characteristics

    advance online publication, 2006-06-06 00:00:00.000;

    doi:10.1038/sj.bjc.6603207

  • Kalbakis, K

    V Georgoulias, A Agelidou, K Syrigos, A Rapti, M Agelidou, J Nikolakopoulos, A Polyzos, A Athanasiadis, E Tselepatiotis, N Androulakis, K Kalbakis, G Samonis and D Mavroudis

    Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine: a multicenter randomised phase II study

    advance online publication, 2005-09-20 00:00:00.000;

    doi:10.1038/sj.bjc.6602748

  • K Kalbakis, Ch Kouroussis, S Kakolyris, D Mavroudis, J Souglakos, S Agelaki, L Vamvakas, M Christodoulakis, K Stylianou and V Georgoulias

    Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracyclin

    doi:10.1054/bjoc.2001.2001

  • Kalden, J R

    R Repp, H H van Ojik, T Valerius, G Groenewegen, G Wieland, C Oetzel, B Stockmeyer, W Becker, M Eisenhut, H Steininger, Y M Deo, G H Blijham, J R Kalden, J G J van de Winkel and M Gramatzki

    Phase I clinical trial of the bispecific antibody MDX-H210 (anti-Fcitalic gammaRI times anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer

    doi:10.1038/sj.bjc.6601367

  • Kalebic, T

    N Voorzanger-Rousselot, F Juillet, E Mareau, J Zimmermann, T Kalebic and P Garnero

    Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation

    advance online publication, 2006-08-01 00:00:00.000;

    doi:10.1038/sj.bjc.6603285

  • Kalemkerian, G P

    Y Ohta, V Shridhar, R K Bright, G P Kalemkerian, W Du, M Carbone, Y Watanabe and H I Pass

    VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours

    doi:10.1038/sj.bjc.6690650

  • Kaletsch, U

    J Schüz, U Kaletsch, R Meinert, P Kaatsch and J Michaelis

    Association of childhood leukaemia with factors related to the immune system

    doi:10.1038/sj.bjc.6690395